• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mitochondrial structural and functional dynamics in Huntington's disease.亨廷顿舞蹈病中的线粒体结构与功能动力学
Brain Res Rev. 2009 Jun;61(1):33-48. doi: 10.1016/j.brainresrev.2009.04.001. Epub 2009 Apr 24.
2
Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.突变型亨廷顿蛋白与线粒体蛋白 Drp1 的相互作用会损害线粒体生物发生,导致亨廷顿病中的轴突运输缺陷和突触退化。
Hum Mol Genet. 2012 Jan 15;21(2):406-20. doi: 10.1093/hmg/ddr475. Epub 2011 Oct 13.
3
Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease.突变型亨廷顿蛋白、异常的线粒体动力学、线粒体轴突运输缺陷以及亨廷顿病中的选择性突触退化。
Biochim Biophys Acta. 2012 Feb;1822(2):101-10. doi: 10.1016/j.bbadis.2011.10.016. Epub 2011 Nov 4.
4
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.亨廷顿病中线粒体动态异常、线粒体缺失和突变亨廷顿寡聚体:对选择性神经元损伤的影响。
Hum Mol Genet. 2011 Apr 1;20(7):1438-55. doi: 10.1093/hmg/ddr024. Epub 2011 Jan 21.
5
Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.亨廷顿病中的线粒体异常与突触损伤:聚焦于有缺陷的线粒体自噬及线粒体靶向治疗
Mol Neurobiol. 2021 Dec;58(12):6350-6377. doi: 10.1007/s12035-021-02556-x. Epub 2021 Sep 14.
6
Effects of overexpression of huntingtin proteins on mitochondrial integrity.亨廷顿蛋白过表达对线粒体完整性的影响。
Hum Mol Genet. 2009 Feb 15;18(4):737-52. doi: 10.1093/hmg/ddn404. Epub 2008 Nov 27.
7
Bioenergetics in Huntington's disease.亨廷顿舞蹈病中的生物能量学
Ann N Y Acad Sci. 1999;893:203-13. doi: 10.1111/j.1749-6632.1999.tb07827.x.
8
Huntington's disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?!亨廷顿舞蹈症与线粒体DNA缺失:是突变亨廷顿蛋白和CAG重复序列扩增的偶然事件还是常规机制?
Cell Mol Neurobiol. 2007 Nov;27(7):867-75. doi: 10.1007/s10571-007-9206-5. Epub 2007 Oct 20.
9
Inhibition of mitochondrial protein import by mutant huntingtin.突变型亨廷顿蛋白抑制线粒体蛋白的输入。
Nat Neurosci. 2014 Jun;17(6):822-31. doi: 10.1038/nn.3721. Epub 2014 May 18.
10
N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking.N端突变型亨廷顿蛋白与线粒体相关联并损害线粒体运输。
J Neurosci. 2008 Mar 12;28(11):2783-92. doi: 10.1523/JNEUROSCI.0106-08.2008.

引用本文的文献

1
Mitochondrial Dysfunction Correlates with Brain Amyloid Binding, Memory, and Executive Function in Down Syndrome: Implications for Alzheimer's Disease in Down Syndrome.线粒体功能障碍与唐氏综合征患者的脑淀粉样蛋白结合、记忆及执行功能相关:对唐氏综合征患者阿尔茨海默病的启示
Brain Sci. 2025 Jan 28;15(2):130. doi: 10.3390/brainsci15020130.
2
Neurotrophin-3 Rescues Striatal Synaptic Plasticity in Model of Neurodegeneration by PLC Signaling Activation.神经生长因子 3 通过 PLC 信号激活挽救神经退行性变模型中的纹状体突触可塑性。
CNS Neurol Disord Drug Targets. 2024;23(12):1488-1498. doi: 10.2174/0118715273298919240531110022.
3
Elucidating the Influence of Lipid Composition on Bilayer Perturbations Induced by the N-terminal Region of the Huntingtin Protein.阐明脂质组成对亨廷顿蛋白N端区域诱导的双层膜扰动的影响。
Biophysica. 2023 Dec;3(4):582-597. doi: 10.3390/biophysica3040040. Epub 2023 Oct 28.
4
Mitochondrial Dysfunction: A Key Player in Brain Aging and Diseases.线粒体功能障碍:脑衰老和疾病中的关键因素
Curr Issues Mol Biol. 2024 Mar 2;46(3):1987-2026. doi: 10.3390/cimb46030130.
5
Mitochondrial protein dysfunction in pathogenesis of neurological diseases.线粒体蛋白功能障碍在神经疾病发病机制中的作用
Front Mol Neurosci. 2022 Sep 7;15:974480. doi: 10.3389/fnmol.2022.974480. eCollection 2022.
6
Mitochondrial Dysregulation and the Influence in Neurodegenerative Diseases.线粒体失调与神经退行性疾病的影响。
Adv Exp Med Biol. 2022;1382:109-118. doi: 10.1007/978-3-031-05460-0_8.
7
Temporal Characterization of Behavioral and Hippocampal Dysfunction in the YAC128 Mouse Model of Huntington's Disease.亨廷顿舞蹈病YAC128小鼠模型中行为和海马功能障碍的时间特征
Biomedicines. 2022 Jun 17;10(6):1433. doi: 10.3390/biomedicines10061433.
8
Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases.靶向线粒体生物能量学作为代谢和神经退行性疾病有前途的治疗策略。
Biomed J. 2022 Oct;45(5):733-748. doi: 10.1016/j.bj.2022.05.002. Epub 2022 May 11.
9
Age-related mitochondrial alterations in brain and skeletal muscle of the YAC128 model of Huntington disease.亨廷顿病YAC128模型中脑和骨骼肌与年龄相关的线粒体改变。
NPJ Aging Mech Dis. 2021 Oct 14;7(1):26. doi: 10.1038/s41514-021-00079-2.
10
Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.亨廷顿病中的线粒体异常与突触损伤:聚焦于有缺陷的线粒体自噬及线粒体靶向治疗
Mol Neurobiol. 2021 Dec;58(12):6350-6377. doi: 10.1007/s12035-021-02556-x. Epub 2021 Sep 14.

本文引用的文献

1
Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.阿尔茨海默病中的β-淀粉样蛋白、线粒体结构与功能动力学
Exp Neurol. 2009 Aug;218(2):286-92. doi: 10.1016/j.expneurol.2009.03.042. Epub 2009 Apr 7.
2
Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice.突变型和野生型亨廷顿蛋白的非等位基因特异性沉默在亨廷顿舞蹈病小鼠模型中显示出治疗效果。
Mol Ther. 2009 Jun;17(6):1053-63. doi: 10.1038/mt.2009.17. Epub 2009 Feb 24.
3
Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models.在两种亨廷顿舞蹈症小鼠模型中,脂肪组织功能障碍与疾病进展相关。
Hum Mol Genet. 2009 Mar 15;18(6):1006-16. doi: 10.1093/hmg/ddn428. Epub 2009 Jan 5.
4
In situ mitochondrial Ca2+ buffering differences of intact neurons and astrocytes from cortex and striatum.来自皮质和纹状体的完整神经元和星形胶质细胞的原位线粒体钙缓冲差异。
J Biol Chem. 2009 Feb 20;284(8):5010-20. doi: 10.1074/jbc.M807459200. Epub 2008 Dec 22.
5
Allele-specific silencing of mutant Huntington's disease gene.突变型亨廷顿舞蹈症基因的等位基因特异性沉默
J Neurochem. 2009 Jan;108(1):82-90. doi: 10.1111/j.1471-4159.2008.05734.x.
6
Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models.线粒体与亨廷顿舞蹈症发病机制:来自遗传和化学模型的见解
Ann N Y Acad Sci. 2008 Dec;1147:358-82. doi: 10.1196/annals.1427.018.
7
Effects of overexpression of huntingtin proteins on mitochondrial integrity.亨廷顿蛋白过表达对线粒体完整性的影响。
Hum Mol Genet. 2009 Feb 15;18(4):737-52. doi: 10.1093/hmg/ddn404. Epub 2008 Nov 27.
8
Weight loss in Huntington disease increases with higher CAG repeat number.亨廷顿舞蹈症患者的体重减轻程度随CAG重复序列数目的增加而加重。
Neurology. 2008 Nov 4;71(19):1506-13. doi: 10.1212/01.wnl.0000334276.09729.0e.
9
Mutant huntingtin and mitochondrial dysfunction.突变型亨廷顿蛋白与线粒体功能障碍
Trends Neurosci. 2008 Dec;31(12):609-16. doi: 10.1016/j.tins.2008.09.004. Epub 2008 Oct 24.
10
Evaluation of Dimebon in cellular model of Huntington's disease.评价 dimebon 在亨廷顿病细胞模型中的作用。
Mol Neurodegener. 2008 Oct 21;3:15. doi: 10.1186/1750-1326-3-15.

亨廷顿舞蹈病中的线粒体结构与功能动力学

Mitochondrial structural and functional dynamics in Huntington's disease.

作者信息

Reddy P Hemachandra, Mao Peizhong, Manczak Maria

机构信息

Neurogenetics Laboratory, Neuroscience Division, Oregon National Primate Research Center, West Campus, Oregon Health and Science University, Beaverton, OR 97006, USA.

出版信息

Brain Res Rev. 2009 Jun;61(1):33-48. doi: 10.1016/j.brainresrev.2009.04.001. Epub 2009 Apr 24.

DOI:10.1016/j.brainresrev.2009.04.001
PMID:19394359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2748129/
Abstract

Huntington's disease (HD) is an autosomal, dominantly inherited neurodegenerative disorder, characterized by chorea, involuntary movements, and cognitive impairments. Tremendous progress has been made since the discovery of HD gene in 1993, in terms of developing animal models to study the disease process, unraveling the expression and function of wild-type and mutant huntingtin (Htt) proteins in the central and peripheral nervous systems, and understanding expanded CAG repeat containing mutant Htt protein interactions with CNS proteins in the disease process. HD progression has been found to involve several pathomechanisms, including expanded CAG repeat protein interaction with other CNS proteins, transcriptional dysregulation, calcium dyshomeostasis, abnormal vesicle trafficking, and defective mitochondrial bioenergetics. Recent studies have found that mutant Htt is associated with mitochondria and causes mitochondrial structural changes, decreases mitochondrial trafficking, and impairs mitochondrial dynamics in the neurons affected by HD. This article discusses recent developments in HD research, with a particular focus on intracellular and intramitochondrial calcium influx, mitochondrial DNA defects, and mitochondrial structural and functional abnormalities in HD development and progression. Further, this article outlines the current status of mitochondrial therapeutics with a special reference to Dimebon.

摘要

亨廷顿舞蹈症(HD)是一种常染色体显性遗传的神经退行性疾病,其特征为舞蹈症、不自主运动和认知障碍。自1993年发现HD基因以来,在开发用于研究疾病进程的动物模型、阐明野生型和突变型亨廷顿蛋白(Htt)在中枢和外周神经系统中的表达及功能,以及了解含扩展CAG重复序列的突变型Htt蛋白在疾病进程中与中枢神经系统蛋白的相互作用等方面均取得了巨大进展。已发现HD的进展涉及多种病理机制,包括扩展的CAG重复序列蛋白与其他中枢神经系统蛋白的相互作用、转录失调、钙稳态失衡、异常囊泡运输以及线粒体生物能量学缺陷。最近的研究发现,突变型Htt与线粒体相关,并导致线粒体结构改变,减少线粒体运输,并损害受HD影响的神经元中的线粒体动力学。本文讨论了HD研究的最新进展,特别关注细胞内和线粒体内钙内流、线粒体DNA缺陷以及HD发生和进展过程中的线粒体结构和功能异常。此外,本文概述了线粒体治疗的现状,并特别提及了Dimebon。